- Home
- CENN vs INKT Comparison
CENN vs INKT Comparison
Compare CENN & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CENN
- INKT
- Stock Information
- Founded
- CENN 2013
- INKT 2017
- Country
- CENN United States
- INKT United States
- Employees
- CENN N/A
- INKT N/A
- Industry
- CENN Auto Manufacturing
- INKT Medicinal Chemicals and Botanical Products
- Sector
- CENN Consumer Discretionary
- INKT Health Care
- Exchange
- CENN Nasdaq
- INKT Nasdaq
- Market Cap
- CENN 30.4M
- INKT 75.7M
- IPO Year
- CENN N/A
- INKT 2021
- Fundamental
- Price
- CENN $0.56
- INKT $16.70
- Analyst Decision
- CENN
- INKT Hold
- Analyst Count
- CENN 0
- INKT 3
- Target Price
- CENN N/A
- INKT $37.50
- AVG Volume (30 Days)
- CENN 669.4K
- INKT 2.9M
- Earning Date
- CENN 08-12-2025
- INKT 08-12-2025
- Dividend Yield
- CENN N/A
- INKT N/A
- EPS Growth
- CENN N/A
- INKT N/A
- EPS
- CENN N/A
- INKT N/A
- Revenue
- CENN $31,097,533.00
- INKT N/A
- Revenue This Year
- CENN N/A
- INKT N/A
- Revenue Next Year
- CENN N/A
- INKT N/A
- P/E Ratio
- CENN N/A
- INKT N/A
- Revenue Growth
- CENN 234.45
- INKT N/A
- 52 Week Low
- CENN $0.51
- INKT $4.56
- 52 Week High
- CENN $1.70
- INKT $76.00
- Technical
- Relative Strength Index (RSI)
- CENN 35.04
- INKT 49.44
- Support Level
- CENN $0.60
- INKT $18.54
- Resistance Level
- CENN $0.65
- INKT $20.25
- Average True Range (ATR)
- CENN 0.04
- INKT 8.24
- MACD
- CENN 0.00
- INKT -1.13
- Stochastic Oscillator
- CENN 27.27
- INKT 13.41
About CENN Cenntro Electric Group Limited
Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles powered by either electricity or hydrogen energy sources. The company's commercial vehicles are designed to serve a variety of fleet and municipal organizations in support of city services, last-mile delivery, and other commercial applications. It has developed a series of commercial vehicle models, including Metro, Logistar, Logimax, Avantier, Teemak, and Antric One. In addition, the company has introduced an open-platform, programmable all-electric iChassis platform, designed for automated and autonomous driving. Geographically, the company generates maximum revenue from vehicle sales in the United States, and also has a presence in Europe, Asia, and other regions.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.